Rapport Therapeutics, Inc. Common Stock
USD41.91
+1.52 (+3.76%)
CEO
Abraham N. Ceesay
IPO Date
2024-06-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$40.40
Prev. Close
$40.39
Day Low
$40.05
Day High
$43.76
52W Low
$11.05
52W High
$43.75
Market Cap
$1.53B
Volume
0.36M
| -4.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 135.7% | -22.4% | -0.08 | 17.14 | -10.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -54.6% | -33.7% | 0.53 | 18.80 | -39.3 |
| -10.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -5.3% | -5.0% | 0.02 | 36.37 | -10.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -10.1% | -9.4% | 0.05 | 22.75 | -3.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -8.4% | -8.0% | 0.03 | 31.01 | -2.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -6.5% | -6.3% | 0.00 | 35.34 | -4.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -5.4% | -5.3% | 0.01 | 45.91 | -5.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -5.4% | -5.2% | 0.01 | 42.08 | -7.1 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 57.2% | -11.0% | -0.05 | 20.10 | -4.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 52.7% | -8.7% | -0.08 | 17.14 | -7.0 |